| Dr Daniel Edward Cannon, MD | |
|
700 W Ironwood Dr Ste 278, Coeur D Alene, ID 83814-4400 | |
| (208) 625-5160 | |
| (208) 625-5733 |
| Full Name | Dr Daniel Edward Cannon |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 15 Years |
| Location | 700 W Ironwood Dr Ste 278, Coeur D Alene, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497997092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | M14014 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kootenai Health | Coeur d'alene, ID | Hospital |
| Bonner General Hospital | Sandpoint, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kootenai Health Inc | 1355792276 | 291 |
| Kootenai Health, Inc. | 4789641598 | 331 |
News Archive
I had always imagined going through pregnancy surrounded by family and friends. But when I found out I was pregnant, my husband, Alex, and I had just moved from San Francisco to Chicago. I knew almost no one.
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. Cell loss due to aging or corneal endothelial disorders, such as Fuchs dystrophy, can lead to cornea edema and blindness, resulting in the need for cornea transplants.
Improved muscle performance starts with better mitochondrial function. Older adults who are overweight may improve their muscle function with a weight loss program that combines exercise and calorie reduction, according to researchers from Florida Hospital, in Orlando, Fla., who present their findings today at the American Physiological Society's Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
› Verified 7 days ago
| Entity Name | Kootenai Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235288655 PECOS PAC ID: 4789641598 Enrollment ID: O20041214000230 |
News Archive
I had always imagined going through pregnancy surrounded by family and friends. But when I found out I was pregnant, my husband, Alex, and I had just moved from San Francisco to Chicago. I knew almost no one.
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. Cell loss due to aging or corneal endothelial disorders, such as Fuchs dystrophy, can lead to cornea edema and blindness, resulting in the need for cornea transplants.
Improved muscle performance starts with better mitochondrial function. Older adults who are overweight may improve their muscle function with a weight loss program that combines exercise and calorie reduction, according to researchers from Florida Hospital, in Orlando, Fla., who present their findings today at the American Physiological Society's Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
› Verified 7 days ago
| Entity Name | Kootenai Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174661151 PECOS PAC ID: 1355792276 Enrollment ID: O20240111003252 |
News Archive
I had always imagined going through pregnancy surrounded by family and friends. But when I found out I was pregnant, my husband, Alex, and I had just moved from San Francisco to Chicago. I knew almost no one.
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. Cell loss due to aging or corneal endothelial disorders, such as Fuchs dystrophy, can lead to cornea edema and blindness, resulting in the need for cornea transplants.
Improved muscle performance starts with better mitochondrial function. Older adults who are overweight may improve their muscle function with a weight loss program that combines exercise and calorie reduction, according to researchers from Florida Hospital, in Orlando, Fla., who present their findings today at the American Physiological Society's Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Edward Cannon, MD 2003 Kootenai Health Way, Coeur D Alene, ID 83814-6051 Ph: (208) 625-5085 | Dr Daniel Edward Cannon, MD 700 W Ironwood Dr Ste 278, Coeur D Alene, ID 83814-4400 Ph: (208) 625-5160 |
News Archive
I had always imagined going through pregnancy surrounded by family and friends. But when I found out I was pregnant, my husband, Alex, and I had just moved from San Francisco to Chicago. I knew almost no one.
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. Cell loss due to aging or corneal endothelial disorders, such as Fuchs dystrophy, can lead to cornea edema and blindness, resulting in the need for cornea transplants.
Improved muscle performance starts with better mitochondrial function. Older adults who are overweight may improve their muscle function with a weight loss program that combines exercise and calorie reduction, according to researchers from Florida Hospital, in Orlando, Fla., who present their findings today at the American Physiological Society's Physiological Bioenergetics: Mitochondria from Bench to Bedside conference in San Diego.
› Verified 7 days ago
Dr. Robert C. Farr, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814 Phone: 208-765-1345 Fax: 208-667-9622 | |
Dr. Ronald J Stout, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814 Phone: 208-765-1345 Fax: 208-667-9622 | |
Dr. Ian M Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr, Suite 278, Coeur D Alene, ID 83814 Phone: 208-625-5160 Fax: 208-625-5733 |